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Abstract     
Furopyrimidines have been known for many years and have been thoroughly examined in the recent years. The present 
review deals with description of the various synthetic routes for  furopyrimidine derivatives.  
Keywords: Furopyrimidines,synthesis, biological importance.     
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Introduction 











, and anti-HCMV (anti-human cytomegalovirus)
7
 activities have 
been described for these compounds. Some of furopyrimidines are active on the blood circulatory system
8
 and can stimulate 
the skin preparative regeneration and increase the efficiency of the antibiotic therapy of Staphylococcus and proteus 
inflected wounds.
9
 The present review deals with description of the various synthetic routes for  furopyrimidine derivatives as 
up till now, to our knowledge, no one study this topic in details in the literature, 
Discussion        
 There are three fundamentals furopyrimidine system. They are Furo[2,3-d]pyrimidine (Ι), furo[3,2-d]pyrimidine (Π) and 










(I) (II) (III)  
      
 The building of furopyrimidine moiety has been achieved either by construction of pyrimidine nucleus on the parent furan 
ring or construction of furan nucleus on the parent pyrimidine ring.  
1.1. From Furan derivatives 
The simple approach to a new pyrimidine ring involves introducing a one-carbon fragment between two suitable and vicinal 
functional groups in furan rings. 
1.1.1. With formamide 
 Formamide reacted with vicinal aminocyano, vicinal acylamino and vicinal aminoester furans to yield the target 
furopyrimidines. 



















           In similar manner, cyclization of 2-amino-5-substitutedfuran-3-carbonitrile derivatives (3i-v) with formamide resulted in 
the formation of 4-amino-6-substitutedfuro[2,3-d] pyrimidine (4i-v).11 
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        (i)  R1 = OCH3 ; (ii)  R
1 = H ; (iii)  R1 = Cl






 Also, cycloaddition of 2-amino-4-arylfuran-3-carbonitrile derivatives (5) with formamide led to the corresponding 4-amino-5-














5                                                                            6
        
R = 4-OMe, 4-NMe2, 4-phenyl and 3-NHAc  
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 By analogy, the synthesis of other fused pyrimidines can be achieved by refluxing of 2-amino-4,5-dimethylfuran-3-

















                                                                     10




    Treatment of 2-amino-4,5-disubstitutedfuran-3-carbonitrile (11a,b)with formamide yielded 4-amino-5,6-
disubstitutedfuro[2,3-d]pyrimidines (12a,b).17  
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11a,b                                                                      12a,b
                         a, R = 2-furyl
                         b, R = 2-thienyl  
          On other hand, furopyrimidines can be obtained from reaction of vicinal acylamino furans. The 2-amino-4-bezoyl-













13                                                                      14
                         
 Also, furopyrimidines can be obtained from reaction of vicinal aminoester furans. The condensation of furan derivatives 

















HCONH2 : DMF : HCO2H





      b, 3-NO2
 16a, 4-NO2
    b, 3-NO2  
 
1.1. 2. With nitrile compounds 
               Nitriles reacted with vicinal aminocyano and vicinal acylamino furans to yield the target furopyrimidines. 















7                                                                           17
         
  Also, the effect of acetonitrile on the compound 7 afforded exclusively fused 4-aminopyrimidines 18, while 
chloroacetonitrile led to the formation of 4-chloropyrimidine 19. These different products can be represented as shown in 































































































R = CH3, C6H5, ClCH2, Cl2CH, CH2CO2C2H5, 

























   On other hand, furopyrimidines can be obtained from reaction of vicinal acylamino furans. Treatment of compound 13 
with malononitrile and trichloroacetonitrile gave 2-cyanomethyl-4,5-diphenylfuro[2,3-d]pyrimidine-6-carbonitrile (24) and 






























































1.1.3. With orthoethers 
               Treatment of compound 7 with triethylorthoformate (T.E.O.F) yielded ethoxymethyleneimine derivative 26 
























    Also, 3-acetamidophenyl-2-aminofuran-3-carbonitrile (27) was treated with T.E.O.F followed by amination and cyclization 



















  Similarly, treatment of 2-amino-5-(m-pyridyl)furan-3-carbonitrile (29) with diethoxymethineacetate afforded an 
ethoxyimino derivative, followed by reaction with ammonia in a solution of ethanol and tetrahydrofuran. Subsequently, 



















 In addition to, 2(α-ethoxyethylideneamino)-4,5-diphenylfuran-3-carbonitrile (31) was obtained by reaction of compound 7 
with triethylorthoacetate (T.E.O.A) in refluxing acetic anhydride. Furthermore, compound 31 was stirred with hydrazine 
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Also, 2-amino-4,5-di-(4-methoxyphenyl)furan-3-carbonitrile (33) reacted with T.E.O.F or T.E.O.A in acetic anhydride 
affording the corresponding imidates 34a,b. The reaction of 34a,b with semicarbazide hydrochloride gave 4-imino-5,6-di-
(p-methoxyphenyl)-3-uriedofuro[2,3-d] pyrimidine 36a and its 2-methyl analogue 36b. The formation of compounds 36a,b 




























































In case of 34a
34a,  R = H




36a,  R = H
    b,  R = CH3  
           On ther hand, the imidoester 34a react with 4-hydroxybenzoylhydrazine (38) giving the amidrazone intermediate 









































































1.1.4. With isothiocyanates 
               Phenyl isothiocyanate reacted with vicinal aminocyano and vicinal acylamino furans to yield the target 
furopyrimidines. Treatment of compound 7 with phenylisothiocyanate at room temperature in the presence of equivalent 


























           On other hand, furopyrimidines can be obtained from reaction of vicinal acylamino furans. Thus, cycloaddition of 
compound 13 with phenylisothiocyanate in dry acetone in the presence of  catalytic amount of piperidine gave 2,3-dihydro-
2-thioxo-3,4,5-triphenylfuro[2,3-d] pyrimidine-6-carbonitrile (42).18 
ISSN 2321-807X 












































13    42  
1.1.5. With acid halide derivatives 
         Reaction of compound 7 with different arenecarbonyl and alkanoyl chlorides (41a-f) under microwave irradiations 
(MWI) in dry media yielded 2-aryl/alkyl-5,6-diphenylfuro[2,3-d] pyrimidin-4(3H)-one (44a-f).
26
 
   Conventionally, a similar cyclization of compound 7 with acyl chlorides (43a-f) to the fused pyrimidin-4-ones (44a-f), as 
reported by Yamazaki et al.,
9



































   Treatment of compound 7 with chloroacetylchloride gave N-chloroacetyl derivative 45, which underwent cyclization with 
potassium thiocyanate to produce the desired furo- 











1.1.6. With formic acid  




















51, R = Me
52, R = Et
50a, R1 = R2 = H
    b, R1 = H, R2 = Me













47                                                                     48
                        
reflux / 61%
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1.1.7. With acid anhydride 
            The reaction of 3-furancarbonitriles 50a-c with acid anhydrides in order to explore the scope of this type of 
reaction was examined. When a mixture of 50a-c, acetic (or propionic) anhydride and tin(IV) chloride was heated in 1,2-








1.1.8. With thiourea derivatives 
            The condensation of aminofuran derivatives 53a,b and N-acetyl-N`-methoxycarbonyl-s-methylthiourea (54)30 in 
the presence of mercury(Π) chloride as catalyst gave the guanidine adducts 55a,b which smoothly converted in sodium 














































54 53a, R = 3-pyridinyl
     b, R = phenyl
 55a, R = 3-pyridinyl
     b, R = phenyl
 56a, R = 3-pyridinyl
     b, R = phenyl  
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1.1.9. With miscellaneous reagents 
              The action of phosgene iminium chloride on the compound 7 in 1,2-dichloroethane was explained by the 














7                                                                              57
Phosgene iminium
       chloride
 
         On the other hand, furo[2,3-d]pyrimidines 60 are prepared via stepwise cyclization reaction of 2-aminofurans 58 




































6058a, R = CO2Me
    b, R = PO(OEt)2
59a, X = CF3
    b, X = CO2Et
 
1.2. From Pyrimidine derivatives 
          The location of the ring oxygen in furo[2,3-d]pyrimidines suggests that pyrimidines bearing an oxygen at C-6 would 
serve as good candidates for developing the furan ring. On the other hand, pyrimidines with an oxygen function at C-5 
represent the most efficient precursors to furo[3,2-d]pyrimidines. Furthermore, virtually all of the syntheses methods lead 
to an oxidized form of the furan ring. 
1.2.1. From uracil and thiouracil derivatives 
         Uracils represent important starting materials which cooperate in construction of the target furopyrimidines. There 
are many derivatives of uracils which served in formation furopyrimidines like halogenated, alkynyl, amino and hydroxy 
uracils. 
 The coupling reaction of halogenated pyrimidinone derivatives 61a-c34 with propargyl alcohol (62) gave the expected 
alkynyl derivatives 63a-c, which could neither be isolated nor detected and furo[2,3-d]pyrimidine derivatives 64a-c were 
obtained in moderate yields.35 
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   69a, R = C4H9
          b, R = C5H11
          c, R = (CH2)ipr




   70a, R = C4H9
          b, R = C5H11
          c, R = (CH2)ipr
































61a, R = CH3; X = OCH3
    b, R = CH3; X = SCH3


























i) Pd-catalyzed  or
ii) 10%Pd/C, reflux
     CuI, acetonitrile
  66a, R = Ph
      b, R = CH2OH 
65    67a, R = Ph
       b, R = CH2OH  
 Also, treatment of 5-iodo-2`-deoxyuridine (68) and alkynyl derivatives 69a-d gave the intermediate 5-alkynyl nucleosides, 
which can be cyclized in situ with copper(Ι) iodide to give 3-(2-deoxy-β-D-ribofurosyl)-6-substituted-2,3-dihydrofuro[2,3-













































R = CH3, PhCH2, C3H5
R` = C7H15, C10H21 
          On the other hand, 5-ethynyl-2`-deoxyuridine (71) was coupled with p-alkylaryliodides 72a-h to achieve the 
corresponding 5-arylethynyl-2`-deoxyuridines (73a-h), which cyclized in the presence of  copper-catalysed to form the 







































R =  CH(CH3)2 , CH2CH(CH3)2 , CH2CH2CH(CH3)2,
       CH2CH2CH2CH(CH3)2 , C(CH3)3 , CH2C(CH3)3,
        CH2CH2C(CH3)3, C6H11
          
 
 By similar manner, 5-Alkynylpyrimidines 75 were reacted with copper (Ι) iodide in the presence of triethylamine to afford 
furo[2,3-d]pyrimidine derivatives 76.39 
 
 
      
 





 Also, Starting from protected C5-alkynyl acyclic nucleosides 1-N-(2-acetoxyethoxymethyl)-5-substituteduracils (77a-d) in 
acetone with silver nitrate, the desired 3-N-(2-acetoxyethoxymethyl)-2,3-dihydro-6-substitutedfuro[2,3-d]pyrimidin-2-ones 
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            On the other hand, 4-aminopyrimidine derivative 79 reacted with α-bromoacetone (80) in dimethylether (DME) to 

















80 81  
 
 The furo[2,3-d]pyrimidin-2(3H)-one (83) can be synthesized via the cyclization of bromovinyldeoxyuracil (82) by using 





























R = tetra-O-acetyl-1/2-D-glucopyranosyl, 





            In addition to, furo[3,2-d]pyrimidine derivatives 87 can be obtained by cyclization of 5-propynyloxypyrimidines 86 


















(1) R = H, Me ; R1 = H
(2) R = R1 = Me
(1) CH3ONa / DMSO
(2) Thermal cyclization

































  90a, R = H
      b, R = CH3
  91a, R = H
      b, R = CH3
Also, the cyclocondesation of 5-(2-methylsulfonyloxyethyl)uracil (88) in the presence of 1,8-diazbicyclo[5.4.0]undec-7-ene 





















  The reaction of 5-(2-hydroxyethyl)-6-methyl-2-thiouracil (90a) or 5-(2-hydroxyethyl)-6-methyl-2-methylthiopyrimidin-
4(3H)-one (90b) with thionyl chloride followed by sodium carbonate treatment led to formation of 5,6-dihydro-4-methyl-2-
thiofuro[2,3-d] pyrimidine (91a) or its 2-methyl analogue (91b), respectively.45 





      
       
              In different manner, 6-allyl-5-hydroxy-1,3-dimethylpyrimidine (92) was cyclized in the presence of benzoyl 

























      Pyrimidin-4,6-diol (94) represented isomer of uracil, which can also be used for synthesis of the target furopyrimidines. 
The reaction of 94 with Z-(2-chloro-2-nitroethenyl)benzene (95), which resulted from condensation of benzaldehyde and 




















1.2.2. From barbituric and thiobarbituric acid derivatives 
           Barbituric acid and thiobarituric acids were used as starting materials in formation of target furopyimidines in wide 
applications.  
 Alkylation of 1,3-dimethylbarbituric acid (96) under phase-transfer conditions with 3-chloro-3-methylbut-1-yne (97) is also 
followed by cyclization to form the corresponding furo[2,3-d] pyrimidine derivative 98. 49 
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 Similarly, reaction of compound 96 with 1,1-diphenylethene (99) in warm acetic acid  and manganese(Π) acetate as 




























99 10096  
   Barbiturylbenzylidenes, which prepared by Perkin condensation of aromatic aldehydes with compound 96, react with 
































         On the other hand, treatment of 1,3-diaryl-2-thiobarbituric acid (102) with benzoin (103) in the presence of a catalytic 


























R = H, Ph, C6H4Me-o, C6H4Me-m, C6H4Me-p,
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 Also, acylation of compound 102 with chloroacetyl chloride (105) in the presence of triethylamine gave  5-chloroacetyl 

































R = H,  C6H4Me-m, C6H4Me-p,C6H4Cl-p, 
      C6H4Br-p,C6H4OMe-o
 
 
            On the other hand, treatment of 5-chloroacetyl-1,3-dimethylbarbituric acid (108a) or 5-chloroacetyl-1,3-diethyl-2-
thiobarbituric acid (108b) with triethylamine resulted in cyclization and gave 1,3-dimethylfuro[2,3-d]pyrimidine-




















a, X= O, R = Me
b, X = S, R = Et
108
109a, X= O, R = Me
b, X = S, R = Et
 
 
 Similarly, the reaction can be started with 5,5-disubstituted barbituric acid derivatives in which one of the substituents 
possesses some reactive group. Thus, O-alkylation occurs in the presence of a dibromo substitent, such as observed with 
barbituric acid derivative 110. The furo[2,3-d]pyrimidine derivative 111 resulted from displacement of the terminal bromine 

















110 111  
1.2.3. From other pyrimidine derivatives 
              There are many of other pyrimidines which be also used in construction of target furopyrimidines. The most 
examples, used for this purpose, were aminopyrimidine, halogenated and alkynyl pyrimidines. 
 The cyclocondensation of 2,6-diamino-3(H)-4-oxo-pyrimidine (112) and chloroacetone (113a) or methyl 4-(3-chloro-2-
oxopropyl)benzoate (113b) gave both 2-amino-4-oxo-6-substituted pyrrolo[2,3-d]pyrimidine (114a,b) and 2,4-diamino-5-
substitutedfuro[2,3-d] pyrimidine (115a,b) in a 2:1 ratio.The yield of 115a by this reported method was 20%,56 while by 
careful  protection of the reaction from light and moisture, the yield was increased to 25%.57,58  
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112   113a,  R =H
































 Similarly, treatment of compound 112 with methylformylchloroacetate (118) in DMSO gave a mixture of pyrrolo[2,3-









































     
      In addition to that, 6-amino-2-phenylpyrimidin-4(3H)-one (121) was reacted with the o-(2,4-dinitrophenyl)oxime of 
chloroacetone  (122), which prepared by condensation of 2,4-dinitrophenol and chloroacetone oxime, in one molar amount 
of sodium or potassium iodide at 120˚C to afford 4-amino-6-(2-hydroxy-3,5-dinitrophenyl)-5-methyl-2-phenylfuro[2,3-d] 
pyrimidine (124). The first step in the formation of 124 involves reaction of pyrimidine 121 as a nucleophile at its oxygen 
with the chlorooxime 122 to give compound 123. This latter is converted into furo[2,3-d]pyrimidine derivative 124 by a 
tautomeric double bond shift, followed by a [3,3] sigmatropic rearrangement, intramolecular cyclisation onto the 
nucleophilic pyrimidine 5-position, and final loss of ammonia. Other structures isomeric with 124 may be drawn which fit 
the spectroscopic data, for example structure 125.62,63 
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            On the other hand, pyrimidine-5-carboxylic acid 126 with thionyl chloride is postulated to involve the intermediate 
127 which cyclized to form the furo[3,4-d]pyrimidine derivative 128. Evidence is presented to support the location of the 





























































  Also, treatment of 4,5-bis(bromoethyl)-2-(methylthio) pyrimidine (129) with DMSO afforded 6-formyl derivative 130a 


















































Ar = Ph, C6H4OMe-p, C6H4OH-p, 2-furyl
133 134
 
 Also, alkynyl pyrimidines were used to form furopyrimidines by cyclocondesation reaction. Thus, heating a solution of 2-
methylthio-4-morpholino-6-phenyl ethynylpyrimidine-5-carbaldehyde (135a) in the presence of bases, the regioselective 
formation of (7Z)-7-benzylidene-5-methoxy-4-morpholino-5,7-dihydrofuro[3,4-d] pyrimidine (136a) took place.68 
 Reaction proceeded smoothly and provided high yields of 138a when 1 equiv. of sodium or potassium methoxide were 
used. However, the reaction of 135a with methanol in the presence of PdCl2(PPh3)2, AgNO3 or CF3CO2Ag proceeded 
with poor regioselectivity and the formation of mixtures of 136a and 5-methoxy-2-methylthio-4-morpholin-4-yl-7-phenyl-5H-
pyrano[4,3-d] pyrimidine (137a) was observed in these cases.69 
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138 139a, Ar = Thiophen-2-yl
      b, Ar = Ph
      c, Ar = 2-tolyl
140a, Ar = Thiophen-2-yl





















+135a, R = N(CH2)4O




  Also, cyclization of 2,6-dimethyl-5-(2-p-tolylethynyl)primidin-4-ol (138) with iodothiophene (139a) furnished 2,4-dimethyl-
5-(thiophen-2-yl)-6-p-tolylfuro[2,3-d] pyrimidine (140a).70 
               On the other hand, the reaction of 138 and iodobenzene (139b) were annulated by palladium-catalyzed 
cyclization to give the furo[2,3-d]pyrimidine derivatives 140b in 33% yield accompanied with the directly cyclized by 
product 141.47 While, when cesium carbonate was used as soft base, the yield of 140b increased to 57% as the major 
product.46As the same as, treatment of 138 with sterically hindered 2-iodotoluene (139c) produced the furo[2,3-d] 
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